JACOB ASSET MANAGEMENT OF NEW YORK LLC - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 44 filers reported holding TRANSPHORM INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JACOB ASSET MANAGEMENT OF NEW YORK LLC ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$555,187
-35.5%
250,084
-1.2%
0.78%
-19.3%
Q2 2023$860,486
-14.8%
253,0840.0%0.97%
-17.6%
Q1 2023$1,009,805
-25.5%
253,084
+1.6%
1.18%
-28.6%
Q4 2022$1,355,017
+7.4%
249,084
-0.7%
1.65%
+20.3%
Q3 2022$1,262,000
+32.0%
250,9440.0%1.37%
+41.9%
Q2 2022$956,000
-63.9%
250,944
-32.9%
0.97%
-40.0%
Q1 2022$2,646,000374,2261.61%
Other shareholders
TRANSPHORM INC shareholders Q4 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,609,346$14,401,2915.31%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$90,477,1602.72%
Worth Venture Partners, LLC 884,802$3,530,3601.72%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,084$1,009,8051.18%
Black Maple Capital Management LP 43,161$172,2120.16%
Polar Asset Management Partners Inc. 709,700$2,831,7030.04%
Soros Fund Management 639,820$2,552,8820.04%
AMERIPRISE FINANCIAL INC 3,929,048$15,676,9010.01%
Stratos Wealth Partners, LTD. 25,640$102,3040.00%
FMR LLC 1,584$6,3200.00%
View complete list of TRANSPHORM INC shareholders